Helping people gain better

We use the latest in thyroid fine needle biopsy techniques with ultrasound guidance. We also use the most advanced technologies for evaluating thyroid biopsy specimens. We participated in a research trial which led to the use of molecular diagnostics for evaluating selected thyroid biopsy specimens and now we routinely use the Affirma gene expression classifier (GEC) to evaluate thyroid biopsy specimens. The Affirma test is done on specimens in which the result is not clearly benign or cancerous. It tests proteins inside of the cells to determine if characteristics are consistent with benign or cancerous findings. This technology has reduced the number of patients requiring surgery.